{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T10:08:01Z","timestamp":1717927681984},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/ndt\/gfh907","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T03:53:28Z","timestamp":1118807608000},"page":"1963-1969","source":"Crossref","is-referenced-by-count":10,"title":["Intravenous iron-gluconate during haemodialysis modifies plasma \u03b22-microglobulin properties and levels"],"prefix":"10.1093","volume":"20","author":[{"given":"Regina","family":"Michelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifra","family":"Sela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batya","family":"Kristal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,6,14]]},"reference":[{"key":"key\n\t\t\t\t20171012200209_BIB1","doi-asserted-by":"crossref","unstructured":"NKF-K\/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis2001; 37 [Suppl 1]: S182\u2013S238","DOI":"10.1016\/S0272-6386(01)70008-X"},{"key":"key\n\t\t\t\t20171012200209_BIB2","doi-asserted-by":"crossref","unstructured":"ERA\/EDTA. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant1999; 14 [Suppl l5]: 1\u201350","DOI":"10.1093\/ndt\/14.suppl_2.61"},{"key":"key\n\t\t\t\t20171012200209_BIB3","doi-asserted-by":"crossref","unstructured":"Esposito BP, Breuer W, Slotki I, Cabantchik ZI. Labile iron in parenteral iron formulations and its potential for generating plasma non-transferrin bound iron (NTBI) in dialysis patients. Eur J Clin Inv2002; 32 [Suppl 1]: 42\u201349","DOI":"10.1046\/j.1365-2362.2002.0320s1042.x"},{"key":"key\n\t\t\t\t20171012200209_BIB4","doi-asserted-by":"crossref","unstructured":"Parkkinen J, von Bonsdorff L, Peltonen S, Gronhagen-Riska C, Rosenlof K. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. Nephrol Dial Transplant2000; 15: 1827\u20131834","DOI":"10.1093\/ndt\/15.11.1827"},{"key":"key\n\t\t\t\t20171012200209_BIB5","doi-asserted-by":"crossref","unstructured":"Lim PS, Wei YH, Yu YL, Kho B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant1999; 14: 2680\u20132687","DOI":"10.1093\/ndt\/14.11.2680"},{"key":"key\n\t\t\t\t20171012200209_BIB6","doi-asserted-by":"crossref","unstructured":"Michelis R, Gery R, Sela S et al. Carbonyl stress induced by intravenous iron during haemodialysis. Nephrol Dial Transplant2003; 18: 924\u2013930","DOI":"10.1093\/ndt\/gfg031"},{"key":"key\n\t\t\t\t20171012200209_BIB7","doi-asserted-by":"crossref","unstructured":"Anraku M, Kitamura K, Shinohara A et al. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int2004; 66: 841\u2013848","DOI":"10.1111\/j.1523-1755.2004.00813.x"},{"key":"key\n\t\t\t\t20171012200209_BIB8","doi-asserted-by":"crossref","unstructured":"Cary NR, Sethi D, Brown EA, Erhardt CC, Woodrow DF, Gower PE. Dialysis arthropathy: amyloid or iron? Br Med J1986; 293: 1392\u20131394","DOI":"10.1136\/bmj.293.6559.1392"},{"key":"key\n\t\t\t\t20171012200209_BIB9","doi-asserted-by":"crossref","unstructured":"Hurst NP, van den Berg R, Disney A et al. \u2018Dialysis related arthropathy\u2019: a survey of 95 patients receiving chronic haemodialysis with special reference to beta 2 microglobulin related amyloidosis. Ann Rheum Dis1989; 48: 409\u2013420","DOI":"10.1136\/ard.48.5.409"},{"key":"key\n\t\t\t\t20171012200209_BIB10","doi-asserted-by":"crossref","unstructured":"H\u00f6rl WH. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol2002; 13 [Suppl 1]: S62\u2013S71","DOI":"10.1681\/ASN.V13suppl_1s62"},{"key":"key\n\t\t\t\t20171012200209_BIB11","doi-asserted-by":"crossref","unstructured":"Drueke TB. Beta2-microglobulin and amyloidosis. Nephrol Dial Transplant2000; 15 [Suppl 1]: 17\u201324","DOI":"10.1093\/oxfordjournals.ndt.a027958"},{"key":"key\n\t\t\t\t20171012200209_BIB12","doi-asserted-by":"crossref","unstructured":"Miyata T, Oda O, Inagi R et al. \u03b22-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest1993; 92: 1243\u20131452","DOI":"10.1172\/JCI116696"},{"key":"key\n\t\t\t\t20171012200209_BIB13","doi-asserted-by":"crossref","unstructured":"DiRaimondo CR, Pollak VE. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse. Am J Kidney Dis1989; 13: 390\u2013395","DOI":"10.1016\/S0272-6386(89)80022-8"},{"key":"key\n\t\t\t\t20171012200209_BIB14","unstructured":"Floege J, Granolleras C, Deschodt G et al. High-flux synthetic versus cellulosic membranes for \u03b22-microglobulin removal during haemodialysis, haemodiafiltration and haemofiltration. Nephrol Dial Transplant1989; 4: 653\u2013657"},{"key":"key\n\t\t\t\t20171012200209_BIB15","doi-asserted-by":"crossref","unstructured":"Locatelli F, Andrulli S, Pecchini F et al. Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant2000; 15: 1399\u20131409","DOI":"10.1093\/ndt\/15.9.1399"},{"key":"key\n\t\t\t\t20171012200209_BIB16","unstructured":"Zingraff J, Beyne P, Urena P et al. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies. Nephrol Dial Transplant1988; 3: 284\u2013290"},{"key":"key\n\t\t\t\t20171012200209_BIB17","doi-asserted-by":"crossref","unstructured":"Moachon N, Boullange C, Fraud S, Vial E, Thomas M, Quash G. Influence of the charge of low molecular weight proteins on their efficacy of filtration and\/or adsorption on dialysis membranes with different intrinsic properties. Biomaterials2002; 23: 651\u2013658","DOI":"10.1016\/S0142-9612(01)00151-X"},{"key":"key\n\t\t\t\t20171012200209_BIB18","doi-asserted-by":"crossref","unstructured":"Clark WR, Macias WL, Molitoris BA, Wang NH. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int1995; 48: 481\u2013488","DOI":"10.1038\/ki.1995.317"},{"key":"key\n\t\t\t\t20171012200209_BIB19","doi-asserted-by":"crossref","unstructured":"Randoux C, Gillery P, Georges N, Lavaud S, Chanard J. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes. Kidney Int2001; 60: 1571\u20131577","DOI":"10.1046\/j.1523-1755.2001.00970.x"},{"key":"key\n\t\t\t\t20171012200209_BIB20","unstructured":"Sethi D, Gower PE. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane. Nephrol Dial Transplant1988; 3: 768\u2013772"},{"key":"key\n\t\t\t\t20171012200209_BIB21","doi-asserted-by":"crossref","unstructured":"Connors LH, Shirahama T, Skinner M, Fenves A, Cohen AS. In vitro formation of amyloid fibrils from intact beta 2-microglobulin. Biochem Biophys Res Commun1985; 131: 1063\u20131068","DOI":"10.1016\/0006-291X(85)90198-6"},{"key":"key\n\t\t\t\t20171012200209_BIB22","doi-asserted-by":"crossref","unstructured":"Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta1996; 1275: 161\u2013203","DOI":"10.1016\/0005-2728(96)00022-9"},{"key":"key\n\t\t\t\t20171012200209_BIB23","doi-asserted-by":"crossref","unstructured":"Kirschbaum B. Hypotransferrinemia of chronically hemodialyzed patients. Artif Organs1999; 23: 1047\u20131054","DOI":"10.1046\/j.1525-1594.1999.06328.x"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/20\/9\/1963\/5233446\/gfh907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:22:44Z","timestamp":1683112964000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/20\/9\/1963\/1850129\/Intravenous-irongluconate-during-haemodialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,14]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2005,6,14]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfh907","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,6,14]]}}}